A detailed history of Great West Life Assurance CO transactions in Incyte Corp stock. As of the latest transaction made, Great West Life Assurance CO holds 182,657 shares of INCY stock, worth $12.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
182,657
Previous 178,583 2.28%
Holding current value
$12.3 Million
Previous $10.2 Million 8.84%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$51.18 - $63.75 $208,507 - $259,717
4,074 Added 2.28%
182,657 $11.1 Million
Q1 2024

May 13, 2024

SELL
$56.55 - $66.59 $1.76 Million - $2.07 Million
-31,115 Reduced 14.84%
178,583 $10.2 Million
Q4 2023

Feb 13, 2024

SELL
$52.16 - $64.19 $800,082 - $984,610
-15,339 Reduced 6.82%
209,698 $13.1 Million
Q3 2023

Nov 14, 2023

SELL
$57.77 - $65.93 $103,292 - $117,882
-1,788 Reduced 0.79%
225,037 $13 Million
Q2 2023

Aug 10, 2023

BUY
$60.95 - $75.51 $2 Million - $2.47 Million
32,764 Added 16.88%
226,825 $14.2 Million
Q1 2023

May 12, 2023

BUY
$70.23 - $86.01 $1.16 Million - $1.42 Million
16,452 Added 9.26%
194,061 $14.1 Million
Q4 2022

Feb 10, 2023

BUY
$67.18 - $84.11 $695,716 - $871,043
10,356 Added 6.19%
177,609 $14.3 Million
Q3 2022

Nov 01, 2022

BUY
$66.18 - $82.86 $11.1 Million - $13.9 Million
167,253 New
167,253 $11.1 Million
Q2 2022

Aug 09, 2022

BUY
$66.18 - $83.18 $899,253 - $1.13 Million
13,588 Added 8.07%
181,916 $13.8 Million
Q1 2022

May 12, 2022

SELL
$66.02 - $79.71 $2.02 Million - $2.44 Million
-30,578 Reduced 15.37%
168,328 $14.1 Million
Q4 2021

Feb 14, 2022

BUY
$63.34 - $74.11 $1.73 Million - $2.02 Million
27,241 Added 15.87%
198,906 $14.6 Million
Q3 2021

Nov 15, 2021

BUY
$68.67 - $84.02 $485,771 - $594,357
7,074 Added 4.3%
171,665 $11.9 Million
Q2 2021

Aug 11, 2021

SELL
$79.87 - $87.53 $364,926 - $399,924
-4,569 Reduced 2.7%
164,591 $13.8 Million
Q1 2021

May 17, 2021

BUY
$76.02 - $100.5 $544,759 - $720,183
7,166 Added 4.42%
169,160 $13.7 Million
Q4 2020

Feb 16, 2021

SELL
$80.74 - $97.7 $252,796 - $305,898
-3,131 Reduced 1.9%
161,994 $14 Million
Q3 2020

Nov 17, 2020

SELL
$85.07 - $109.69 $2.27 Million - $2.93 Million
-26,714 Reduced 13.93%
165,125 $0
Q3 2020

Nov 13, 2020

BUY
$85.07 - $109.69 $2.12 Million - $2.73 Million
24,874 Added 14.9%
191,839 $0
Q2 2020

Aug 17, 2020

BUY
$74.18 - $108.93 $1.48 Million - $2.17 Million
19,929 Added 13.55%
166,965 $17.3 Million
Q1 2020

May 14, 2020

SELL
$63.18 - $85.97 $3.1 Million - $4.22 Million
-49,105 Reduced 25.04%
147,036 $10.8 Million
Q4 2019

Feb 11, 2020

BUY
$73.04 - $95.72 $4.06 Million - $5.33 Million
55,632 Added 39.59%
196,141 $0
Q3 2019

Oct 25, 2019

BUY
$72.82 - $86.52 $972,729 - $1.16 Million
13,358 Added 10.51%
140,509 $10.4 Million
Q2 2019

Jul 31, 2019

SELL
$73.52 - $88.7 $287,095 - $346,373
-3,905 Reduced 2.98%
127,151 $0
Q1 2019

May 08, 2019

BUY
$63.56 - $88.17 $1.51 Million - $2.09 Million
23,741 Added 22.12%
131,056 $11.2 Million
Q4 2018

Feb 12, 2019

BUY
$58.5 - $69.94 $39,838 - $47,629
681 Added 0.64%
107,315 $6.5 Million
Q3 2018

Nov 13, 2018

SELL
$61.75 - $74.23 $1.23 Million - $1.48 Million
-19,878 Reduced 15.71%
106,634 $7.37 Million
Q2 2018

Aug 10, 2018

BUY
$60.85 - $83.98 $153,281 - $211,545
2,519 Added 2.03%
126,512 $8.48 Million
Q1 2018

May 10, 2018

BUY
$83.06 - $100.98 $7,807 - $9,492
94 Added 0.08%
123,993 $10.3 Million
Q4 2017

Feb 09, 2018

BUY
$93.56 - $116.6 $194,604 - $242,528
2,080 Added 1.71%
123,899 $11.7 Million
Q3 2017

Nov 09, 2017

BUY
$109.15 - $138.27 $13.3 Million - $16.8 Million
121,819
121,819 $13.8 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.